Free. Unsubscribe any time.
Royalty Pharma plc (RPRX)
Royalty Pharma plc filed 35 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 70 transactions and 1,937,588 shares. None carries the SEC's AFF10B5ONE flag; all 35 name a plan in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2026-08-19, came 2 days after the one before it (2026-08-17) and reports 2 transactions against 2 in the filing before it.
- The sales it reports total 100,000 shares, 88,998 more than the 11,002 in the filing before it.
- Its 35 filings on file run from 2025-11-19 to 2026-08-19, and state 7 plan adoption dates, from 2025-08-08 to 2026-03-20.
Trades in Royalty Pharma plc 70
- Coyne Terrance P. — 2025-11-17 · S · 65,844 shares
- Coyne Terrance P. — 2025-11-17 · S · 3,750 shares
- Lloyd George W. — 2025-11-19 · S · 47,798 shares
- Lloyd George W. — 2025-11-19 · S · 4,628 shares
- Lloyd George W. — 2025-11-19 · S · 47,401 shares
- Lloyd George W. — 2025-11-19 · S · 4,599 shares
- Lloyd George W. — 2025-11-19 · S · 25,530 shares
- Lloyd George W. — 2025-11-19 · S · 2,470 shares
- Lloyd George W. — 2025-11-19 · S · 2,770 shares
- Lloyd George W. — 2025-11-19 · S · 230 shares
- Coyne Terrance P. — 2025-11-24 · S · 55,146 shares
- Coyne Terrance P. — 2025-11-24 · S · 10,686 shares
Adoption dates in Royalty Pharma plc 7
- 2025-08-08 — stated in 12 filings
- 2025-08-20 — stated in 3 filings
- 2025-08-29 — stated in 2 filings
- 2025-09-16 — stated in 8 filings
- 2026-02-12 — stated in 4 filings
- 2026-02-24 — stated in 2 filings
- 2026-03-20 — stated in 3 filings
Results prints in Royalty Pharma plc 0
Trades before a print in Royalty Pharma plc 0
Interval to Royalty Pharma plc’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 70no later print
Adoption dates Royalty Pharma plc states
- 2025-08-08 in 12 filings
- 2025-08-20 in 3 filings
- 2025-08-29 in 2 filings
- 2025-09-16 in 8 filings
- 2026-02-12 in 4 filings
- 2026-02-24 in 2 filings
- 2026-03-20 in 3 filings
Filing text: “10b5-1 plan adopted by the Reporting Person on March 20, 2026”
Sources: SEC EDGAR full-text search and the SEC submissions API.
The address of this record
Royalty Pharma plc’s insider trading plan record — 35 Form 4 statements in the 2025 filing year — is published at one address, this page. When you cite or link the record, use https://velarionrecords.com/plan10b5/issuer/0001802768.